Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

Enuresis in Children

AI Summary
  • Intermittent nocturnal incontinence in children older than five years requires evaluation; classify as primary or secondary and as monosymptomatic or non-monosymptomatic.
  • Assessment should rule out underlying pathology, identify comorbidities such as sleep-disordered breathing, behavioural disorders, constipation, and use a frequency volume chart.
  • Treat MNE with enuresis alarm and desmopressin; add anticholinergic or beta3 agents; ensure adherence before diagnosing refractory cases.
Summarise with AI (MRCPsych/FRANZCP)

Indian J Pediatr. 2026 Feb 18. doi: 10.1007/s12098-026-06025-y. Online ahead of print.

ABSTRACT

Enuresis, also known as nocturnal enuresis or bedwetting, refers to intermittent incontinence during sleep. It warrants medical attention, in children older than five years of age, or earlier if desired by the child or family, due to its significant emotional and psychological impact on quality of life. Children who have never achieved nighttime continence are diagnosed with primary enuresis, while those who begin bedwetting after at least six months of being dry, with secondary enuresis. The condition is further classified as monosymptomatic (MNE) or non-monosymptomatic (NMNE), depending on the absence or presence of lower urinary tract symptoms. Assessment, thus, focuses on ruling out underlying pathological causes and determining the phenotype as mentioned above. Comorbid conditions such as sleep-disordered breathing, behavioral or psychiatric disorders, and constipation should be identified. A frequency-volume chart is a valuable tool in both diagnosis and management. All families in select cases should receive basic urotherapy. The mainstays of MNE treatment are an enuresis alarm and desmopressin. Anticholinergic or β3-adrenergic agents may be added to desmopressin. Imipramine is considered a third-line agent. Management of NMNE requires targeted treatment of the associated lower urinary tract condition. Comorbidities must also be addressed appropriately. Therapy-resistant and treatment-refractory enuresis should be diagnosed only after ensuring adherence to prescribed therapies. A range of alternative therapies may be explored and individualized based on the patient’s needs.

PMID:41706319 | DOI:10.1007/s12098-026-06025-y

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD